Investors & Media
Press Releases
2020
-
- September 29, 2020
-
Anokion Appoints Patricia Allen to its Board of Directors
Read More
-
- September 24, 2020
-
Anokion Announces FDA Clearance of IND Application for ANK-700 for the Treatment of Multiple Sclerosis
Read More
-
- September 22, 2020
-
Anokion Announces Expansion of Exclusive Collaboration with Bristol Myers Squibb to Develop Novel Treatments for Autoimmune Diseases
Read More
-
- May 26, 2020
-
Anokion to Participate in Jefferies 2020 Virtual Healthcare Conference
Read More
-
- February 27, 2020
-
Anokion Announces Initiation of Patient Dosing in Phase 1 Clinical Trial of KAN-101 in Celiac Disease
Read More
-
- February 24, 2020
-
Anokion to Present at the Cowen 40th Annual Healthcare Conference
Read More
-
- February 19, 2020
-
Anokion to Present at the 3rd Antigen Specific Immune Tolerance Summit
Read More
-
- January 21, 2020
-
Anokion Announces FDA Clearance of IND Application for its Lead Program in Celiac Disease
Read More
-
- January 08, 2020
-
Anokion to Participate in Autoimmune and Inflammatory Disease Panel at 2020 Biotech Showcase
Read More